Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 35: 211-214, 1989;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Macart, M.
Right arrow Articles by Guilbaud, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Macart, M.
Right arrow Articles by Guilbaud, J. C.

Clinical Chemistry, Vol 35, 211-214, Copyright © 1989 by American Association for Clinical Chemistry

Optimized microturbidimetric assay for fibrinogen

M Macart, A Koffi, G Henocque, JF Mathieu and JC Guilbaud
Laboratoire du Centre Hospitalier de Laon, France.

In this assay we measure the turbidity produced by precipitation of plasma fibrinogen with a reagent composed of ammonium sulfate, EDTA, and guanidine hydrochloride. The two-step reagent addition, and use of fixed reaction times, eliminates interference from bilirubin, hemoglobin, and chylomicrons. We checked 135 monoclonal proteins for interference, finding the probability of encountering major interference in samples from adults to be very low, P = 0.0002. The method is calibrated with purified fibrinogen and the response is linear over the range 0-10 g/L. Within-run precision (CV) is less than 2% from 1 to 10 g/L. Correlations with the immunoturbidimetric (r = 0.99), chronometric (r = 0.99), and clotting (r = 0.97) methods were extremely high.


The following articles in journals at HighWire Press have cited this article:


Home page
 J. Nutr.Home page
T. Preston, C. Slater, D. C. McMillan, J. S. Falconer, A. Shenkin, and K. C. H. Fearon
Fibrinogen Synthesis Is Elevated in Fasting Cancer Patients with an Acute Phase Response
J. Nutr., August 1, 1998; 128(8): 1355 - 1360.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Z.-F. Yin, Z.-F. Huang, J. Cui, R. Fiehler, N. Lasky, D. Ginsburg, and G. J. Broze Jr.
Prothrombotic phenotype of protein Z deficiency
PNAS, June 6, 2000; 97(12): 6734 - 6738.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Association for Clinical Chemistry.